A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer: Results of the Sentinella/GIVOM Trial CME

Disclosures

Release Date: March 14, 2008Valid for credit through March 14, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s) for physicians

Contents of This CME Activity
    To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

  1. A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer: Results of the Sentinella/GIVOM Trial
    Giorgio Zavagno, MD
    Gian Luca De Salvo, MD
    Giuliano Scalco, MD
    Fernando Bozza, MD
    Luca Barutta, MD
    Paola Del Bianco, MSc
    Marco Renier, MD
    Carlo Racano, MD
    Paolo Carraro, MD
    Donato Nitti, MD

Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 

Medscape

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the purpose of sentinel lymph node (SLN) biopsy
  2. Describe steps in the SLN biopsy procedure
  3. List potential complications of SLN and axillary lymph node dissection (ALND)
  4. Describe the accuracy and false-negative rate associated with SLN biopsy
  5. Compare the adverse effects of SLN and ALND
Authors and Disclosures

Giorgio Zavagno, MD
Disclosure: Giorgio Zavagno, MD, has disclosed no relevant financial relationships.


Gian Luca De Salvo, MD
Disclosure: Gian Luca De Salvo, MD, has disclosed no relevant financial relationships.


Giuliano Scalco, MD
Disclosure: Giuliano Scalco, MD, has disclosed no relevant financial relationships.


Fernando Bozza, MD
Disclosure: Fernando Bozza, MD, has disclosed no relevant financial relationships.


Luca Barutta, MD
Disclosure: Luca Barutta, MD, has disclosed no relevant financial relationships.


Paola Del Bianco, MSc
Disclosure: Paola Del Bianco, MSc, has disclosed no relevant financial relationships.


Marco Renier, MD
Disclosure: Marco Renier, MD, has disclosed no relevant financial relationships.


Carlo Racano, MD
Disclosure: Carlo Racano, MD, has disclosed no relevant financial relationships.


Paolo Carraro, MD
Disclosure: Paolo Carraro, MD, has disclosed no relevant financial relationships.


Donato Nitti, MD
Disclosure: Donato Nitti, MD, has disclosed no relevant financial relationships.


Désirée Lie, MD, MSEd
Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships.


Layton F. Rikkers, MD
Disclosure: Layton F. Rikkers, MD, has disclosed no relevant financial relationships.


Pamela Nevar, MS, RD
Disclosure: Pamela Nevar, MS, RD, has disclosed no relevant financial relationships.


Carol Peckham
Disclosure: Carol Peckham has disclosed no relevant financial relationships.


 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.